Skip to main content
. 2022 Sep 14;17:4163–4193. doi: 10.2147/IJN.S380697

Table 3.

Characteristics of NP-Based Nanoformulations with Cyclopamine or All-Trans Retinoic Acid

Natural Products Nanomaterials Co-Loaded Size (nm) PDI Zeta Potential (mV) Entrapment Efficiency (%) Drug Loading (%) Target CSCs Mechanism Refs
Cyclopamine Hyaluronic acid functional amphipathic and redox-responsive polymer particles Doxorubicin 245.3 0.11 - 58.2/70.6 - Breast cancer ↓ The number and size of tumor spheres [130]
N-(2-hydroxypropyl)methacrylamide copolymer - - - - - - Prostate cancer ↓ CD133 [131]
N-(2-hydroxypropyl)methacrylamide copolymer-cyclopamine/docetaxel conjugate - - - - - 6.6/7.2 Prostate cancer ↑ Apoptosis
↓ CD133+CSCs
[132]
mPEG-b-PCC-g-PTX/CYP-g-DC Paclitaxel 76.37 ± 0.15 0.273 - 14.50 ± 1.60 5.36 ± 0.07 Prostate cancer ↓ Hedgehog signaling and colony formation
↑ Tumor suppressor miRNA expression
[133]
All-trans retinoic acid Nanoparticles Doxorubicin 151.6 - 1.8 40.01 3.05 Breast cancer ↑ Differentiation of CSCs [137]
Albumin nanoparticles - 180.63 ± 0.38 0.180 ± 0.007 32.1 ± 0.42 93 8.37 Lung cancer ↑ Uptake of ATRA, apoptosis
↓ Cell growth
[138]
Lipid-polymer nanoparticles - 125.2 ± 9.9 0.18 ± 0.08 -16.3 ± 7.2 86.4 ± 5.6 10.5 ± 4.5 Osteosarcoma ↓ CD44+ CSCs [139]
Nanoparticles - 106.7 ± 8.7 0.17 ± 0.18 -11.5 ± 5.3 84.5 ±  6.9 8.4 ± 3.4 Gastric cancer ↓ CD44+ and CD133+ gastric CSCs [140]
FA-modified chitosan (CSO)-derived polymer micelles Doxorubicin 73.34 0.209 25.4 - - Breast cancer ↑ Apoptosis
↓ Stemness and metastasis
[142]
Stealth liposomes - 81.1 ± 0.8 nm 0.18 ± 0.01 -6.1± 1.4 >90 9.3 ± 0.1 Breast cancer ↑ Differentiation and cell cycle arrest
↓ Proliferation
[143]
Electrospun polycaprolactone nanofibers - 929 - - 86.2 12.17 Glioblastoma ↑ Differentiation
↑ Effect of photothermal therapy
[144]
Gold nanostars-dendritic polyglycerol - 68.1 - 13.9 - 54.5 Breast cancer ↓ Stemness gene expression, tumor sphere formation, self-renewal and tumor growth [145]

Notes: PDI, polydispersity index;↑, increase or promote;↓, decrease or inhibit; -, no data available.